Tsingke Showcases at AACR 2025 -- Advancing Global Cancer Research with Integrated Synthesis Solutions

What Tsingke Offers for Oncology Research What Tsingke Offers for Oncology Research Building a Global Synthesis Engine for Cancer Innovation Tsingke is committed to enabling biotech companies, CDMOs, and academic researchers with a one-stop synthesis platform—from molecular design and synthesis to expression and functional validation. By supporting critical steps in target discovery, validation, and preclinical development, we help accelerate the path from lab to clinic. Interested in...
Comunicato Precedente

next
Comunicato Successivo

next

What Tsingke Offers for Oncology Research

Building a Global Synthesis Engine for Cancer Innovation

Tsingke is committed to enabling biotech companies, CDMOs, and academic researchers with a one-stop synthesis platform—from molecular design and synthesis to expression and functional validation. By supporting critical steps in target discovery, validation, and preclinical development, we help accelerate the path from lab to clinic.

Interested in learning more or discussing a custom solution?
Reach out to us at [email protected] or visit www.tsingke.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/tsingke-showcases-at-aacr-2025--advancing-global-cancer-research-with-integrated-synthesis-solutions-302456314.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;